We characterized a transgenic mouse model of MSA-C (MBP29) developed by over-expressing human aSyn with the oligodendrocyte specific myelin basic protein promoter (MBP) resulting in accumulation of aSyn in GCI of oligodendrocytes [23]. The gene discussed is MBP; the disease is multiple system atrophy, cerebellar type.